V Wealth Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

V Wealth Advisors’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-29	Closed	–	–	862
2017 Q2	$0	Buy	+29	New	+$12	﹤0.01%	859

Other funds holding GCVRZ

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

V Wealth Advisors's GCVRZ Position: Q3 2017 in Review

V Wealth Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2017, closing a stake of 29 shares.

V Wealth Advisors first reported a position in GCVRZ in Q2 2017 and held it in 1 quarter. The position peaked at $0 in Q2 2017. 111 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2017.

V Wealth Advisors reported no remaining Sanofi Contingent Value Rights position as of Q3 2017 after selling out during the quarter.
V Wealth Advisors sold 29 Sanofi Contingent Value Rights shares in Q3 2017.
V Wealth Advisors first reported a position in Sanofi Contingent Value Rights in Q2 2017 and held it in 1 quarter.
V Wealth Advisors's Sanofi Contingent Value Rights position peaked at $0 in Q2 2017.
111 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2017.

Based on V Wealth Advisors's 13F filing for Q3 2017, filed 12 Oct 2017.